I G 342 Pill - yellow capsule/oblong, 16mm
Pill with imprint I G 342 is Yellow, Capsule/Oblong and has been identified as Naproxen 500 mg. It is supplied by Cipla USA, Inc.
Naproxen is used in the treatment of Back Pain; Ankylosing Spondylitis; Bursitis; Muscle Pain; Chronic Myofascial Pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Naproxen 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I G 342
Naproxen
- Imprint
- I G 342
- Strength
- 500 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA, Inc.
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Inactive Ingredients
-
croscarmellose sodium,
povidone,
ferric oxide yellow,
ferric oxide red,
silicon dioxide,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
31722-0342 | Camber Pharmaceuticals, Inc. |
68084-0127 (Discontinued) | Amerisource Health Services |
Related images for "I G 342"
More about naproxen
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (681)
- Drug images
- Latest FDA alerts (8)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Patient resources
Other brands
Aleve, Naprosyn, Anaprox, Flanax Pain Reliever, ... +6 more
Professional resources
- Naproxen monograph
- Naproxen (FDA)
- Naproxen CR Tablets (FDA)
- Naproxen Capsules (FDA)
- Naproxen Delayed Release (FDA)
- Naproxen Tablets (FDA)
Other brands
Aleve, Naprosyn, Naprelan, All Day Pain Relief, All Day Relief
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.